Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America
Dunlay SM, Givertz MM, Aguilar D, et al.
Circulation. 2019 Jun 6:CIR0000000000000691.
Leggi
Verde
Le Breaking News di colore verde sono relative a linee-guida, consensus, statement ecc.
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guideline
Arnett DK, Blumenthal RS, Albert MA, et al.
J Am Coll Cardiol. Pub. online 17 March 2019
Leggi
Management of blood cholesterol – Clinical Guidelines Synopsis AHA/ACC
Alenghat FJ, Davis AM
JAMA. Published online February 4 2019
Leggi
Standards of Medical Care in Diabetes – 2019
American Diabetes Association
Ahmann AJ, Aroda VR, Barbour LA, et al.
Diabetes Care. 2019;42(S1):S1-2.
Leggi
2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease – A report of the American College of Cardiology task force on expert consensus decision pathways
Das SR, Everett BM, Birtcher KK, et al.
J Am Coll Cardiol. 2018;72(24):3200-23
Leggi
Diagnosis and management of nonalcoholic fatty liver disease
Paul S, Davis AM
JAMA. Published online, 26 November 2018.
Leggi
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Davies MJ, D’Alessio DA, Fradkin J, et al.
Diabetologia. Pub. online 5 October 2018
Leggi
Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
JAMA 2018;320(11):1163-71
Leggi
Medicines for Treatment Intensification in Type 2 Diabetes and Type of Insulin in Type 1 and Type 2 Diabetes in Low-Resource Settings: Synopsis of the World Health Organization Guidelines on Second- and Third-Line Medicines and Type of Insulin for the Control of Blood Glucose Levels in Nonpregnant Adults With Diabetes Mellitus
Roglic G, Norris SL
Annals of Internal Medicine. 2018;169(5):1-4
Leggi
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Niessner A, Tamargo J, Koller L, et al.
European Heart Journal. 2018;39(24):2274-81
Leggi